Literature DB >> 12900899

Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.

Bryan Lo1, M Faiyaz-Ul-Haque, S Kennedy, R Aviv, L-C Tsui, Ahmad S Teebi.   

Abstract

Cherubism is a rare autosomal dominant inherited condition caused by mutations in the c-Abl-binding protein SH3BP2. It is characterized by multiple cystic giant cell lesions of the jaw appearing in early childhood with stabilization and remission after puberty. In the present study, we used direct sequence analysis of the SH3BP2 gene of several individuals from a family with cherubism to search for additional SH3BP2 mutations resulting in cherubism. In affected relatives, we found a previously unreported G to A transition in exon 9 leading to a Gly to Arg substitution at amino acid position 420. G420R has been reported previously with a G to C transversion. To date there have been no disease causing mutations outside exon 9. Therefore, the amino acid sequence from positions 415 to 420 may represent a specific protein domain which, when disrupted, leads to the cherubism phenotype. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900899     DOI: 10.1002/ajmg.a.20226

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  Cherubism: case report with review of literature.

Authors:  Divya Mehrotra; Abhishek Kesarwani
Journal:  J Maxillofac Oral Surg       Date:  2011-03-22

2.  3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.

Authors:  Miguel A de la Fuente; Lalit Kumar; Bao Lu; Raif S Geha
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.

Authors:  Steven A Lietman; Lihong Yin; Michael A Levine
Journal:  J Orthop Res       Date:  2010-11       Impact factor: 3.494

4.  Genetic study of an Indian family with cherubism.

Authors:  Ankur Singh; Khushbu Singh; Ruchi Goel; Ying Hu; Ernst Reichenberger; Seema Kapoor
Journal:  Indian J Pediatr       Date:  2013-09-05       Impact factor: 1.967

5.  Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter - Case Report.

Authors:  L Preda; O Dinca; A Bucur; C Dragomir; E Severin
Journal:  Mol Syndromol       Date:  2010-06-09

6.  Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings.

Authors:  Francisco J Martínez-Tello; Palmira Manjón-Luengo; Manuel Martin-Pérez; Santiago Montes-Moreno
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

Review 7.  Poly(ADP-ribose)-dependent ubiquitination and its clinical implications.

Authors:  Christina A Vivelo; Vinay Ayyappan; Anthony K L Leung
Journal:  Biochem Pharmacol       Date:  2019-05-08       Impact factor: 5.858

8.  Neurofibromatosis presenting with a cherubism phenotype.

Authors:  C I van Capelle; P H G Hogeman; C J M van der Sijs-Bos; B G F Heggelman; B Idowu; P J Slootweg; A R M Wittkampf; A M Flanagan
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

9.  SH3BP2 is an activator of NFAT activity and osteoclastogenesis.

Authors:  Steven A Lietman; Lihong Yin; Michael A Levine
Journal:  Biochem Biophys Res Commun       Date:  2008-04-25       Impact factor: 3.575

10.  Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of "myositis ossificans-like lesions" are the early phases in the formation of soft-tissue aneurysmal bone cyst.

Authors:  William R Sukov; Marcello F Franco; Michele Erickson-Johnson; Margaret M Chou; K Krishnan Unni; Doris E Wenger; Xiaoke Wang; Andre M Oliveira
Journal:  Skeletal Radiol       Date:  2008-02-12       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.